Identifying a Baicalein-related Prognostic signature Contributes to prognosis prediction and Tumor Microenvironment of Pancreatic Cancer

The high-throughput sequencing analysis was employed to explore the biological roles of baicalein in PDAC cells. We conducted the high-throughput sequencing of RNA to compare the RNA expression pattern between no treated Highly Metastatic potential SUIT-2 cells and baicalein treated Highly Metastatic potential SUIT-2 cells. The total RNA was extracted from cells using RTIzol RNA isolation reagent according to the manufacturer's instructions. The transcriptome was evaluated by RNA sequencing which was performed at Novogene Bioinformatics Institute (China).